U.S. health officials have warned that people with weak immune systems face a heightened risk from COVID this winter, because omicron subvariants threaten to knock out antibody treatments.
The FDA, in a notice Wednesday, said bebtelovimab is no longer authorized for use because it is not expected to neutralize the omicron BQ.1 and BQ.1.1 subvariants.
President Joe Biden has called on people with weak immune systems to consult with their physicians about what extra precautions they should take this winter to stay safe. The Health and Human Services Department is putting on hold pending requests for bebtelovimab, and the manufacturer Eli Lilliy has also halted commercial distribution of the antibody treatment until further notice, according to the FDA notice.Sign up for NECN newsletters.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Study suggests persistent immune activation and long COVID correlate independently with severe COVID-19Researchers investigated whether severe COVID-19 patients exhibited inflammation and immune activation three months after hospitalization and explored the associations among COVID-19 severity, long COVID, and immune activation.
Lire la suite »
MPs told COVID jabs are not up to scratch by former chief of UK's vaccination programmeThe former head of the vaccines taskforce has said the current COVID jabs are 'not good enough'.
Lire la suite »
Twitter gives up fight against COVID-19 misinformationEx-moderation lead says he does not feel the platform is 'safe' under Musk
Lire la suite »
Notts builder blames Brexit and Covid for housing estate delaysCustomers are moving into incomplete properties
Lire la suite »
UK playing with fire after Covid jabs U-turn, warn scientistsDame Kate Bingham, the former head of the UK vaccines taskforce, said the country had 'lost its leadership' of Covid-19 preparedness
Lire la suite »